Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Shorter hormone therapy for prostate cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.02.20
Views: 172
Rating:

Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada

Dr André-Guy Martin speaks to ecancer at EMUC 2019 in Vienna about an improved regimen of hormone therapy.

He outlines a recent study which showed little difference in overall survival if you used a long term hormone therapy regimen.

Dr Martin suggests a shorter regimen for those patients who do not tolerate the therapy particularly well.

Related videos

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation